一种循环可以通过结合异常暴露的SNAP25来向质母细胞瘤
Alberto G Arias1, Laura Tovar-Martinez2,3, Eliana K Asciutto4
1Medical Physics Department, Gerencia de Área Aplicaciones Nucleares a la Salud (GAANS)Centro Atómico Bariloche, Avenida Bustillo 9500, San Carlos de Bariloche R8402AGP, Argentina.
Molecular pharmaceutics
|November 22, 2024
概括
一种新型循环,CES,通过与突触体相关蛋白25 (SNAP25) 结合来向质母细胞瘤 (GBM). 这种具有针对性药物输送的潜力,SNAP25可以作为GBM诊断标记物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 特定于瘤的分子变化对于理解疾病机制和开发诊断/治疗标志物至关重要.
- 质母细胞瘤 (GBM) 仍然是一个具有挑战性的脑瘤,需要改进的向疗法.
研究的目的:
- 为了识别和表征一种新,专门针对GBM.
- 为了阐明已识别的的分子受体.
- 评估及其受体对GBM诊断和药物输送的潜力.
主要方法:
- 在U87MG和WT-GBM模型中静脉注射循环CESPLLSEC (CES).
- 亲和染色法用于识别瘤提取物中的CES结合伙伴.
- 光标记,直接结合测定和流动细胞计量以确认受体相互作用.
- 在体外光动力学治疗试验中使用CES-药物联合体.
- 表面等离子体共振和分子建模以研究受体-连接体相互作用.
主要成果:
- 在内GBM模型中专门积累的CES和与血管系统相关.
- 突触体相关蛋白25 (SNAP25) 被确定为CES受体.
- CES证明了对SNAP25的特定结合,SNAP25在细胞表面表达在GBM中,而不是正常组织中.
- 对于SNAP25+ GBM细胞系,CES-药物结合物表现出选择性细胞毒性.
- SNAP25与V原和VI原结合,在结合地点方面可能与CES竞争.
结论:
- CES是一种有前途的,用于向向质母细胞瘤的向药物输送.
- SNAP25是GBM诊断的潜在分子标记物,也是治疗的目标.
- CES,SNAP25和细胞外矩阵组件之间的相互作用需要进一步研究.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...